Skip to Content

Green Thumb Industries Inc GTII Stock Quote

| Rating as of

Morningstar‘s Stock Analysis GTII

Valuation
Currency in CAD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Inflation Pressure Weakens in Green Thumb’s Q2; Continued Share Price Decline Unwarranted

Analyst Note

| Kristoffer Inton |

Inflation pressure weakened in Green Thumb’s second quarter, leading to stabilization in sales and margins compared with the contraction in the first quarter. Revenue was up 5% sequentially, buoyed by sequential comparable growth of 10%. This compares with flat first-quarter sequential revenue growth and a 6% decline in sequential comparable sales as inflation pressured cannabis’ share of wallet. Adjusted operating EBITDA margin recovered nicely to 31%, after having shrunk massively to 28% during the first quarter. We’ve made slight adjustments to our forecasts, but not enough to change our U.S. dollar-denominated fair value estimate of $45 per share for no-moat Green Thumb. Our Canadian dollar-denominated fair value estimate rises to CAD 58 from CAD 57 on exchange rate changes.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics GTII

Company Profile GTII

Business Description

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 15 states and operates roughly 75 cannabis stores under the chains Rise and Essence. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including Dr. Solomon’s, Dogwalkers, and Beboe.

Contact
325 West Huron Street, Suite 412
Chicago, IL, 60654
T +1 312 471-6720
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Stock Type
Employees 3,730